3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
48
Lung Neoplasms
24
Carcinoma, Hepatocellular
24
Small Cell Lung Carcinoma
16
Urinary Bladder Neoplasms
12
Cholangiocarcinoma
12
Breast Neoplasms
10
Biliary Tract Neoplasms
10
Neoplasms
9
Neoplasm Metastasis
9
Liver Neoplasms
9
Pancreatic Neoplasms
7
Carcinoma
6
Endometrial Neoplasms
5
Colorectal Neoplasms
5
Triple Negative Breast Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Neoplasms by Site
4
Gallbladder Neoplasms
4
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Respiratory Tract Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Bile Duct Neoplasms
3
Adenocarcinoma
3
Thyroid Neoplasms
2
Thoracic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Interventions
Pemetrexed
4
Spinal Puncture
3
Radiotherapy
3
aflutinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Bevacizumab
2
toripalimab
1
sintilimab
1
pertuzumab
1
lorlatinib
1
azeliragon
1
adavosertib
1
Trastuzumab
1
Referral and Consultation
1
Radiation
1
Physical Examination
1
Immunotherapy, Adoptive
1
Immune Checkpoint Inhibitors
1
GDC-0084
1
Drug Therapy
1
Deferoxamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
durvalumab
×
90 days
×
Clear all
No trials found.